Physician profile
Roberto Morales
NPI 1417989500
$1,402.99
in general payments reported to CMS, 2019-2025
16 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $238 · 2021: $185 · 2022: $108 · 2023: $118 · 2024: $267 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580 · Education: $92.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.35 |
| Education | $92.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $305.20 | 2020-2025 | Slynd, Twirla |
| Hologic Sales and Service, LLC | $191.50 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $191.03 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $188.48 | 2019-2024 | |
| Abbvie INC. | $132.20 | 2019-2023 | |
| Astellas Pharma US INC | $105.22 | 2023-2025 | Veozah, Myrbetriq |
| Millicent US INC | $52.79 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $41.11 | 2022 | |
| Daiichi Sankyo INC. | $40.09 | 2019-2020 | |
| Avion Pharmaceuticals | $36.11 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $32.31 | 2021 | |
| Ethicon US, LLC | $24.46 | 2024 | Dermabond |
| Zyla Life Sciences, INC. | $21.61 | 2020 | |
| Therapeuticsmd, INC. | $18.23 | 2022 | |
| Agile Therapeutics, INC. | $14.10 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $8.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.